Seeking Alpha
Then came the show-me-the-money slump, as it takes a while for a sales force to actually get traction for a cancer therapy. At the bottom of the slump, in late 2006, you could buy the stock for under $11 per share. Then in 2007 there was another ramp ...
http://seekingalpha.com/article/288167-onyx-pharma-s-prospects-look-bright
No comments:
Post a Comment